These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 18232062
1. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes. Boyle PJ, Zrebiec J. Diabetes Metab Res Rev; 2008; 24(4):257-85. PubMed ID: 18232062 [Abstract] [Full Text] [Related]
2. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone. Thomas RM, Aldibbiat A, Griffin W, Cox MA, Leech NJ, Shaw JA. Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290 [Abstract] [Full Text] [Related]
3. [Hypoglycemia--a dreaded complication of diabetes]. Bjørgaas M. Tidsskr Nor Laegeforen; 2000 Aug 30; 120(20):2441-4. PubMed ID: 11475234 [Abstract] [Full Text] [Related]
4. Hypoglycaemic valleys: an under-recognised problem in type 2 diabetes? Frier BM. Int J Clin Pract Suppl; 2002 Jul 30; (129):12-9. PubMed ID: 12166599 [Abstract] [Full Text] [Related]
5. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D. Diabetes Obes Metab; 2008 Jun 30; 10 Suppl 1():16-24. PubMed ID: 18435670 [Abstract] [Full Text] [Related]
6. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP, DARTS/MEMO Collaboration. Diabet Med; 2005 Jun 30; 22(6):749-55. PubMed ID: 15910627 [Abstract] [Full Text] [Related]
7. Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy. Barnett AH. Curr Med Res Opin; 2010 Jun 30; 26(6):1333-42. PubMed ID: 20370379 [Abstract] [Full Text] [Related]
8. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study. Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel. Curr Med Res Opin; 2009 Nov 30; 25(11):2643-54. PubMed ID: 19751116 [Abstract] [Full Text] [Related]
9. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus. Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R. Patient Educ Couns; 2008 Oct 30; 73(1):50-9. PubMed ID: 18583087 [Abstract] [Full Text] [Related]
10. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review. Noh RM, Graveling AJ, Frier BM. Expert Opin Pharmacother; 2011 Oct 30; 12(14):2161-75. PubMed ID: 21668402 [Abstract] [Full Text] [Related]
11. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes. de Galan BE, Schouwenberg BJ, Tack CJ, Smits P. Neth J Med; 2006 Sep 30; 64(8):269-79. PubMed ID: 16990690 [Abstract] [Full Text] [Related]
12. Hypoglycaemia: current management and controversies. Choudhary P, Amiel SA. Postgrad Med J; 2011 Apr 30; 87(1026):298-306. PubMed ID: 21296797 [Abstract] [Full Text] [Related]
13. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel. Int J Clin Pract; 2009 Mar 30; 63(3):522-31. PubMed ID: 19187170 [Abstract] [Full Text] [Related]
14. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial. Fajardo Montañana C, Hernández Herrero C, Rivas Fernández M. Diabet Med; 2008 Aug 30; 25(8):916-23. PubMed ID: 18959604 [Abstract] [Full Text] [Related]
15. The effect of an education programme (HyPOS) to treat hypoglycaemia problems in patients with type 1 diabetes. Hermanns N, Kulzer B, Kubiak T, Krichbaum M, Haak T. Diabetes Metab Res Rev; 2007 Oct 30; 23(7):528-38. PubMed ID: 17245692 [Abstract] [Full Text] [Related]
16. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes. Baxter MA. Acta Diabetol; 2008 Dec 30; 45(4):253-68. PubMed ID: 18766296 [Abstract] [Full Text] [Related]
17. Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Barnett AH, Cradock S, Fisher M, Hall G, Hughes E, Middleton A. Int J Clin Pract; 2010 Jul 30; 64(8):1121-9. PubMed ID: 20236369 [Abstract] [Full Text] [Related]
18. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study. Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group. Diabetes Obes Metab; 2008 Mar 30; 10(3):212-22. PubMed ID: 18269636 [Abstract] [Full Text] [Related]
19. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine. Janka HU. Diabetes Obes Metab; 2008 Jul 30; 10 Suppl 2():35-41. PubMed ID: 18577155 [Abstract] [Full Text] [Related]
20. Study design and baseline characteristics of patients in the PRESENT study. Shestakova M, Bech OM, Momani MS. Diabetes Res Clin Pract; 2008 Sep 30; 81 Suppl 1():S3-9. PubMed ID: 18672309 [Abstract] [Full Text] [Related] Page: [Next] [New Search]